Subscribe to RSS
DOI: 10.1055/s-0030-1258339
3-Methoxalylchromone - A Versatile Reagent for the Regioselective Synthesis of 1-Desazapurine
Publication History
Publication Date:
26 November 2010 (online)

Abstract
The reaction of 5-amino-1H-imidazoles with 3-methoxalylchromone provided a set of imidazo[4,5-b]pyridines (1-desazapurines) bearing the CO2Me substituent at the α-position of the pyridine core. The corresponding acids were synthesized by subsequent hydrolysis of the ester function. Being typical purine isosteres, 1-desazapurines are considered to be potent pharmacophores, and are widely used in drug design and medicinal chemistry.
Key words
3-methoxalylchromone - 5-aminoimidazoles - imidazo[4,5-b]pyridines - 1-desazapurines - cyclocondensations
- 1a
Middleton WR.Wibberley DG. J. Heterocycl. Chem. 1980, 17: 1757 ; and references thereinReference Ris Wihthout Link - 1b
Bukowski L.Janowiec M. Pharmazie 1988, 43: 315 ; and references thereinReference Ris Wihthout Link - 1c
Chakravarty PK.Naylor EM.Chen A.Chang RSL.Chen T.Faust KA.Lotti VJ.Kivlighn SD.Gable RA.Zingaro GJ.Schorn TW.Schaffer LW.Broten TP.Siegl PKS.Patchett AA.Greenlee WJ. J. Med. Chem. 1994, 37: 4068 ; and references thereinReference Ris Wihthout Link - 1d
Mantlo NB.Chakravarty PK.Ondeyka DL.Siegl PKS.Chang R.-S.Lotti VJ.Faust KA.Chen TB.Schirn TW.Sweet CS.Emmert SE.Patchett AA.Greenlee WJ. J. Med. Chem. 1991, 34: 919 ; and references thereinReference Ris Wihthout Link - 1e
Mederski WKR.Pachler KGR. Tetrahedron 1992, 48: 10549Reference Ris Wihthout Link - 1f For a recent review on
the biological activity of imidazo[4,5-b]pyridines,
see:
Dubey PK.Kumar RV.Naidu A.Kulkarni SM. Asian J. Chem. 2002, 14: 1129Reference Ris Wihthout Link - 2a
Duncia JV.Carini DJ.Chiu AT.Johnson AL.Price WA.Wong PC.Wexler RR.Timmermans PBMW. Med. Res. Rev. 1992, 12: 149Reference Ris Wihthout Link - 2b
De Laszlo SE.Quagliato CS.Greenlee WJ.Patchett AA.Chang RSL.Lotti VJ.Chen T.-B.Scheck SA.Faust KA.Kivlighn SS.Schorn TS.Zingaro GJ.Siegl PKS. J. Med. Chem. 1993, 36: 3207 ; and references thereinReference Ris Wihthout Link - 2c
Curtin ML.Davidsen SK.Heyman HR.Garland RB.Sheppard GS.Florjancic AS.Xu L.Carrera GM.Steinman DH.Trautmann JA.Albert DH.Magoc TJ.Tapang P.Rhein DA.Conway RG.Luo G.Denissen JF.Marsh KC.Morgan DW.Summers JB. J. Med. Chem. 1998, 41: 74Reference Ris Wihthout Link - 2d
Janssens F.Torremans J.Janssen M.Stokbroekx RA.Luyckx M.Janssen PAJ. J. Med. Chem. 1985, 28: 1943Reference Ris Wihthout Link - 3
Clark RL.Pessolano AA.Shen T.-Y.Jocobus DP.Jones H.Lotti VJ.Flataker LM. J. Med. Chem. 1978, 21: 965 - 4
Robinson MM, andFinch N. inventors; U.S. Patent 3719683.Reference Ris Wihthout Link - 5
Von Bebenberg W. inventors; U.S. Patent 3819640.Reference Ris Wihthout Link - 6
Lesher GY,Brundage RP,Opalka CJ, andPage DF. inventors; French Patent 2,478,637. ; Chem. Abstr. 1982, 96, 85551kReference Ris Wihthout Link - 7
Kuezynski L.Mrozikiewiez A.Poreba K. Pol. J. Pharmacol. Pharm. 1982, 34: 229 - 8
Bianchi M.Butti A.Rossi S.Barzaghi F.Marcaria V. Eur. J. Med. Chem. 1983, 18: 501 - 9a
Vaughn JR. inventors; U.S. Patent 2637731.Reference Ris Wihthout Link - 9b
Röchling HFW,Büchel K.-H, andKorte FWAGK. inventors; U.S. Patent 3459759.Reference Ris Wihthout Link - 10a
Wexler RR.Greenlee WJ.Irvin JD.Goldberg MR.Prendergast K.Smith RD.Timmermans PBMWM. J. Med. Chem. 1996, 39: 625Reference Ris Wihthout Link - 10b
Schmidt B.Schieffer B. J. Med. Chem. 2003, 46: 2261 ; and references thereinReference Ris Wihthout Link - 11a
Mantlo NB.Chakravarty PK.Ondeyka DL.Siegl PKS.Chang RS.Lotti VJ.Faust KA.Chen T.-B.Schorn TW.Sweet CS.Emmert SE.Patchett AA.Greenlee WJ. J. Med. Chem. 1991, 34: 2919Reference Ris Wihthout Link - 11b
Kim D.Mantlo NB.Chang RS.Kivlighn SD.Greenlee WJ. Bioorg. Med. Chem. Lett. 1994, 4: 41Reference Ris Wihthout Link - 11c
Mantlo NB.Chang RSL.Siegl PKS. Bioorg. Med. Chem. Lett. 1993, 3: 1693Reference Ris Wihthout Link - 12a
Rizzo M.Ventrice D.Monforte F.Procopio S.De Sarro G.Anzini M.Cappelli A.Makovec F. J. Pharm. Biomed. Anal. 2004, 35: 321Reference Ris Wihthout Link - 12b
Rizzo M.Anzini M.Cappelli A.Vomero S.Ventrice D.De Sarro G.Procopio S.Costa N.Makovec F. Farmaco 2003, 58: 837Reference Ris Wihthout Link - 13a
Bavetsias V.Sun C.Bouloc N.Reynisson J.Workman P.Linardopoulos S.McDonald E. Bioorg. Med. Chem. Lett. 2007, 17: 6567Reference Ris Wihthout Link - 13b
Chan F.Sun C.Perumal M.Nguyen Q.-D.Bavetsias V.McDonald E.Martins V.Wilsher N.Valenti M.Eccles S.Poele R.Workman P.Aboagye EO.Linardopoulos S. Mol. Cancer Ther. 2007, 6: 3147Reference Ris Wihthout Link - 14a
Cristalli G.Costanzi S.Lambertucci C.Lupidi G.Vittori S.Volpini R.Camaioni E. Med. Res. Rev. 2001, 21: 105Reference Ris Wihthout Link - 14b
Maydanovych O.Beal PA. Chem. Rev. 2006, 106: 3397Reference Ris Wihthout Link - 14c
Nair V. IMPDH inhibitors: Discovery of antiviral agents against emerging diseases, In Antiviral Drug Discovery for Emerging Diseases and Bioterrorism ThreatsTorrence PF. John Wiley & Sons, Inc; Hoboken: 2005. Chap. 8. p.179-202Reference Ris Wihthout Link - 14d
Shu Q.Nair V. Med. Res. Rev. 2008, 219Reference Ris Wihthout Link - 14e
Erion MD.Reddy MR. J. Am. Chem. Soc. 1998, 120: 3295Reference Ris Wihthout Link - 15
Hedstrom L. Chem. Rev. 2009, 109: 2903 - 16a
Ghosh CK. J. Heterocycl. Chem. 1983, 20: 1437Reference Ris Wihthout Link - 16b
Sabitha G. Aldrichimica Acta 1996, 29: 15Reference Ris Wihthout Link - 16c
Sosnovskikh VYa.Moshkin VS.Kodess MI. Tetrahedron Lett. 2008, 49: 6856Reference Ris Wihthout Link - 17
Volochnyuk DM.Ryabukhin SV.Plaskon AS.Grygorenko OO. Synthesis 2009, 3719 - 18
Mkrtchyan S.Iaroshenko VO.Dudkin S.Gevorgyan A.Vilches-Herrera M.Ghazaryan G.Volochnyuk DM.Ostrovskyi D.Zeeshan A.Villinger A.Sosnovskikh VY.Langer P. Org. Biomol. Chem. 2010, 8: 5280 - 19a
Iaroshenko VO.Sevenard DV.Kotljarov AV.Volochnyuk DM.Tolmachev AO.Sosnovskikh VYa. Synthesis 2009, 731Reference Ris Wihthout Link - 19b
Iaroshenko VO.Wang Y.Sevenard DV.Volochnyuk DM. Synthesis 2009, 1851Reference Ris Wihthout Link - 19c
Iaroshenko VO.Sevenard DV.Volochnyuk DM.Wang Y.Martiloga A.Tolmachev AO. Synthesis 2009, 1865Reference Ris Wihthout Link - 19d
Iaroshenko VO.Wang Y.Zhang B.Volochnyuk DM.Sosnovskikh VYa. Synthesis 2009, 2393Reference Ris Wihthout Link - 19e
Kotljarov A.Irgashev RA.Iaroshenko VO.Sevenard DV.Sosnovskikh VYa. Synthesis 2009, 3233Reference Ris Wihthout Link - 19f
Kotljarov A.Iaroshenko VO.Volochnyuk DM.Irgashev RA.Sosnovskikh VYa. Synthesis 2009, 3869Reference Ris Wihthout Link - 19g
Iaroshenko VO. Synthesis 2009, 3967Reference Ris Wihthout Link - 19h
Ostrovskyi D.Iaroshenko VO.Petrosyan A.Dudkin S.Ali I.Villinger A.Tolmachev A.Langer P. Synlett 2010, 2299Reference Ris Wihthout Link - 20a
Gammill RB. Synthesis 1979, 901Reference Ris Wihthout Link - 20b
Yokoe I.Maruyama K.Sugita Y.Harashida T.Shirataki Y. Chem. Pharm. Bull. 1994, 42: 1697Reference Ris Wihthout Link
References
Crystallographic data (excluding structure factors) for the structures of 7a and 9b, reported in this paper, have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication nos. CCDC 799366 for 7a and CCDC 799367 for 9b. These data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; Fax: +44 (1223)336033; E-mail: deposit@ccdc.cam.ac.uk, or via www.ccdc.cam.ac.uk/data_request/cif
22Iaroshenko, V. O.; Mkrtchyan, S.; Ghazaryan, G.; Hakopyan, A.; Maalik, A.; Supe, L.; Ostrovskyi, D.; Villinger, A.; Tolmachev, A.; Sosnovskikh, V. Ya.; Langer, P. manuscript in preparation.